Orbimed Advisors as of Dec. 31, 2021
Portfolio Holdings for Orbimed Advisors
Orbimed Advisors holds 158 positions in its portfolio as reported in the December 2021 quarterly 13F filing
Company (Ticker) | Portfolio Weight | Valued At | Change in Shares | Share Count | Share Price |
---|---|---|---|---|---|
Springworks Therapeutics (SWTX) | 4.8 | $374M | 6.0M | 61.98 | |
Bristol Myers Squibb (BMY) | 3.5 | $271M | 4.3M | 62.35 | |
Horizon Therapeutics Pub L SHS | 3.5 | $269M | 2.5M | 107.76 | |
Boston Scientific Corporation (BSX) | 3.0 | $236M | 5.6M | 42.48 | |
Theseus Pharmaceuticals | 2.7 | $214M | 17M | 12.68 | |
Edgewise Therapeutics (EWTX) | 2.7 | $213M | 14M | 15.28 | |
Mirati Therapeutics | 2.7 | $209M | 1.4M | 146.69 | |
Pmv Pharmaceuticals (PMVP) | 2.2 | $169M | 7.3M | 23.10 | |
Pfizer (PFE) | 2.0 | $154M | 2.6M | 59.05 | |
Ikena Oncology Nonvoting | 1.9 | $149M | 12M | 12.54 | |
Humana (HUM) | 1.9 | $148M | 318k | 463.86 | |
Abbvie (ABBV) | 1.9 | $145M | 1.1M | 135.40 | |
Vertex Pharmaceuticals Incorporated (VRTX) | 1.9 | $145M | 658k | 219.60 | |
Edwards Lifesciences (EW) | 1.8 | $139M | 1.1M | 129.55 | |
Merck & Co (MRK) | 1.8 | $136M | 1.8M | 76.64 | |
UnitedHealth (UNH) | 1.7 | $136M | 271k | 502.14 | |
Intuitive Surgical Com New (ISRG) | 1.7 | $134M | 374k | 359.30 | |
Natera (NTRA) | 1.7 | $132M | 1.4M | 93.39 | |
Adicet Bio (ACET) | 1.7 | $130M | 7.4M | 17.49 | |
Arcutis Biotherapeutics (ARQT) | 1.6 | $126M | 6.1M | 20.74 | |
Prelude Therapeutics (PRLD) | 1.6 | $125M | 10M | 12.45 | |
Stryker Corporation (SYK) | 1.6 | $124M | 465k | 267.42 | |
Guardant Health (GH) | 1.6 | $123M | 1.2M | 100.02 | |
Iovance Biotherapeutics (IOVA) | 1.6 | $121M | 6.3M | 19.09 | |
Spdr Ser Tr S&p Biotech (XBI) | 1.5 | $113M | 1.0M | 111.96 | |
Seagen | 1.3 | $101M | 656k | 154.60 | |
Turning Point Therapeutics I | 1.3 | $101M | 2.1M | 47.70 | |
Hca Holdings (HCA) | 1.3 | $100M | 390k | 256.92 | |
Tricida | 1.3 | $98M | 10M | 9.56 | |
Keros Therapeutics (KROS) | 1.3 | $98M | 1.7M | 58.51 | |
Crinetics Pharmaceuticals In (CRNX) | 1.2 | $91M | 3.2M | 28.41 | |
Meiragtx Holdings (MGTX) | 1.1 | $89M | 3.7M | 23.74 | |
Dex (DXCM) | 1.1 | $82M | 153k | 536.95 | |
Neurocrine Biosciences (NBIX) | 1.0 | $79M | 932k | 85.17 | |
BioMarin Pharmaceutical (BMRN) | 1.0 | $76M | 861k | 88.35 | |
Sinovac Biotech SHS (SVA) | 0.9 | $73M | 2.8M | 25.60 | |
Zimmer Holdings (ZBH) | 0.9 | $72M | 564k | 127.04 | |
Repare Therapeutics Ord (RPTX) | 0.9 | $70M | 3.3M | 21.09 | |
Compass Therapeutics (CMPX) | 0.9 | $69M | 22M | 3.17 | |
Kinnate Biopharma | 0.9 | $68M | 3.8M | 17.72 | |
Theravance Biopharma (TBPH) | 0.8 | $66M | 6.0M | 11.05 | |
Thermo Fisher Scientific (TMO) | 0.8 | $63M | 95k | 667.24 | |
Abcellera Biologics (ABCL) | 0.8 | $60M | 4.2M | 14.30 | |
Silverback Therapeutics (SPRY) | 0.7 | $58M | 8.7M | 6.66 | |
Alpine Immune Sciences | 0.7 | $57M | 4.1M | 13.85 | |
Janux Therapeutics (JANX) | 0.7 | $56M | 2.8M | 19.73 | |
Biogen Idec (BIIB) | 0.7 | $55M | 230k | 239.92 | |
Si-bone (SIBN) | 0.7 | $51M | 2.3M | 22.21 | |
89bio (ETNB) | 0.6 | $49M | 3.7M | 13.07 | |
Gracell Biotechnologies Sponsored Ads | 0.6 | $48M | 7.9M | 6.04 | |
Passage Bio (PASG) | 0.6 | $44M | 7.0M | 6.35 | |
Syndax Pharmaceuticals (SNDX) | 0.6 | $43M | 2.0M | 21.89 | |
Oak Street Health | 0.5 | $43M | 1.3M | 33.14 | |
Xtant Med Hldgs Com New (XTNT) | 0.5 | $41M | 73M | 0.56 | |
Neuropace (NPCE) | 0.5 | $40M | 4.0M | 10.08 | |
Galapagos Nv Spon Adr (GLPG) | 0.5 | $40M | 717k | 55.13 | |
Tela Bio (TELA) | 0.5 | $39M | 3.0M | 12.80 | |
Verona Pharma Sponsored Ads (VRNA) | 0.5 | $38M | 5.7M | 6.72 | |
Ikena Oncology (IKNA) | 0.5 | $37M | 2.9M | 12.54 | |
Select Medical Holdings Corporation (SEM) | 0.5 | $36M | 1.2M | 29.40 | |
Adagio Therapeutics (IVVD) | 0.5 | $36M | 5.0M | 7.26 | |
Oric Pharmaceuticals (ORIC) | 0.4 | $34M | 2.3M | 14.70 | |
Nanostring Technologies (NSTGQ) | 0.4 | $34M | 807k | 42.23 | |
Gh Research Ordinary Shares (GHRS) | 0.4 | $33M | 1.4M | 23.33 | |
Sierra Oncology Com New | 0.4 | $32M | 1.5M | 21.74 | |
Cytek Biosciences (CTKB) | 0.4 | $31M | 1.9M | 16.32 | |
ImmunoGen | 0.4 | $29M | 3.9M | 7.42 | |
Mereo Biopharma Group Ads (Principal) (MREO) | 0.4 | $28M | 17M | 1.60 | |
Terns Pharmaceuticals (TERN) | 0.3 | $27M | 3.8M | 7.07 | |
Vaxcyte (PCVX) | 0.3 | $26M | 1.1M | 23.79 | |
Erasca (ERAS) | 0.3 | $26M | 1.7M | 15.58 | |
Evolent Health Cl A (EVH) | 0.3 | $26M | 938k | 27.67 | |
Vectivbio Hldg Ord Shs | 0.3 | $26M | 5.2M | 4.91 | |
Ventyx Biosciences (VTYX) | 0.3 | $26M | 1.3M | 19.86 | |
Vistagen Therapeutics Com New | 0.3 | $25M | 13M | 1.95 | |
Tenet Healthcare Corp Com New (THC) | 0.3 | $24M | 299k | 81.69 | |
Singular Genomics Systems In | 0.3 | $24M | 2.1M | 11.56 | |
Scpharmaceuticals (SCPH) | 0.3 | $24M | 4.8M | 5.02 | |
Jounce Therapeutics | 0.3 | $24M | 2.9M | 8.35 | |
Chinook Therapeutics | 0.3 | $23M | 1.4M | 16.31 | |
Decibel Therapeutics | 0.3 | $23M | 4.9M | 4.65 | |
Harpoon Therapeutics | 0.3 | $22M | 2.9M | 7.55 | |
Gilead Sciences (GILD) | 0.3 | $21M | 288k | 72.61 | |
Applied Therapeutics (APLT) | 0.3 | $21M | 2.3M | 8.95 | |
Xenon Pharmaceuticals (XENE) | 0.3 | $20M | 631k | 31.24 | |
Logicbio Therapeutics | 0.3 | $20M | 8.5M | 2.31 | |
Graphite Bio | 0.3 | $20M | 1.6M | 12.43 | |
Mersana Therapeutics (MRSN) | 0.2 | $18M | 2.9M | 6.22 | |
Chemomab Therapeutics Sponsored Ads (CMMB) | 0.2 | $18M | 2.6M | 6.90 | |
Danaher Corporation 5% Conv Pfd B (Principal) | 0.2 | $17M | 10k | 1738.20 | |
Curis Com New | 0.2 | $17M | 3.6M | 4.76 | |
Illumina (ILMN) | 0.2 | $17M | 45k | 380.44 | |
Gemini Therapeutics | 0.2 | $17M | 5.8M | 2.91 | |
Milestone Pharmaceuticals (MIST) | 0.2 | $17M | 2.6M | 6.55 | |
Corvus Pharmaceuticals (CRVS) | 0.2 | $17M | 6.9M | 2.41 | |
Nextcure (NXTC) | 0.2 | $16M | 2.7M | 6.00 | |
Celldex Therapeutics Com New (CLDX) | 0.2 | $16M | 406k | 38.64 | |
Rxsight (RXST) | 0.2 | $16M | 1.4M | 11.25 | |
D Fluidigm Corp Del (LAB) | 0.2 | $15M | 3.8M | 3.92 | |
Synlogic | 0.2 | $15M | 6.0M | 2.42 | |
Aclaris Therapeutics (ACRS) | 0.2 | $14M | 986k | 14.54 | |
Aeglea Biotherapeutics | 0.2 | $14M | 3.0M | 4.75 | |
Pulmonx Corp (LUNG) | 0.2 | $14M | 435k | 32.07 | |
Cytomx Therapeutics (CTMX) | 0.2 | $14M | 3.2M | 4.33 | |
Burning Rock Biotech Sponsored Ads | 0.2 | $14M | 1.5M | 9.53 | |
Fusion Pharmaceuticals | 0.2 | $13M | 3.2M | 4.17 | |
Amgen (AMGN) | 0.2 | $13M | 57k | 224.97 | |
Cybin Ord (CYBN) | 0.2 | $13M | 11M | 1.19 | |
Cullinan Oncology (CGEM) | 0.2 | $12M | 805k | 15.43 | |
Galecto (GLTO) | 0.2 | $12M | 4.1M | 3.03 | |
Uniqure Nv SHS (QURE) | 0.2 | $12M | 586k | 20.74 | |
Bellus Health Com New | 0.2 | $12M | 1.5M | 8.04 | |
Sonendo (SONX) | 0.1 | $11M | 2.0M | 5.76 | |
9 Meters Biopharma | 0.1 | $10M | 10M | 0.98 | |
Magenta Therapeutics | 0.1 | $10M | 2.3M | 4.43 | |
Prometheus Biosciences | 0.1 | $9.9M | 250k | 39.54 | |
Imara | 0.1 | $9.9M | 4.4M | 2.25 | |
Vor Biopharma (VOR) | 0.1 | $9.7M | 833k | 11.62 | |
Acutus Medical (AFIB) | 0.1 | $9.0M | 2.6M | 3.41 | |
CVRX (CVRX) | 0.1 | $8.8M | 723k | 12.23 | |
Rapt Therapeutics (RAPT) | 0.1 | $8.0M | 217k | 36.73 | |
Achilles Therapeutics Sponsored Ads (ACHL) | 0.1 | $7.9M | 1.6M | 5.01 | |
Gossamer Bio (GOSS) | 0.1 | $7.7M | 683k | 11.31 | |
Graybug Vision Com Shs | 0.1 | $7.6M | 4.2M | 1.83 | |
Oncocyte | 0.1 | $7.6M | 3.5M | 2.17 | |
Nautilus Biotechnology (NAUT) | 0.1 | $7.5M | 1.5M | 5.18 | |
Nanostring Technologies Note 2.625% 3/0 (Principal) | 0.1 | $7.2M | 6.0M | 1.20 | |
Aerovate Therapeutics (AVTE) | 0.1 | $6.3M | 536k | 11.79 | |
Intellia Therapeutics (NTLA) | 0.1 | $6.3M | 53k | 118.23 | |
Syros Pharmaceuticals | 0.1 | $6.0M | 1.8M | 3.26 | |
Protara Therapeutics Com Stk (TARA) | 0.1 | $5.6M | 831k | 6.75 | |
Nurix Therapeutics (NRIX) | 0.1 | $5.3M | 185k | 28.95 | |
Sarepta Therapeutics (SRPT) | 0.1 | $5.3M | 59k | 90.05 | |
I Mab Sponsored Ads (IMAB) | 0.1 | $5.3M | 111k | 47.39 | |
Health Sciences Acq Corp 2 Ord Shs | 0.1 | $5.0M | 500k | 10.08 | |
Century Therapeutics (IPSC) | 0.1 | $4.9M | 307k | 15.86 | |
Chardan Healthcare Acqu- Ord (PHGE) | 0.1 | $4.5M | 2.8M | 1.60 | |
Alx Oncology Hldgs (ALXO) | 0.1 | $4.5M | 208k | 21.49 | |
Inflarx Nv (IFRX) | 0.1 | $4.2M | 875k | 4.76 | |
Talaris Therapeutics | 0.0 | $3.8M | 247k | 15.29 | |
Field Trip Health Ord | 0.0 | $3.7M | 1.5M | 2.42 | |
Inozyme Pharma (INZY) | 0.0 | $3.6M | 527k | 6.82 | |
Sight Sciences (SGHT) | 0.0 | $3.5M | 200k | 17.57 | |
X4 Pharmaceuticals (XFOR) | 0.0 | $3.1M | 1.4M | 2.29 | |
Aadi Bioscience (AADI) | 0.0 | $3.1M | 128k | 24.15 | |
Exscientia Ads (EXAI) | 0.0 | $2.5M | 125k | 19.76 | |
Surface Oncology | 0.0 | $2.2M | 468k | 4.78 | |
Aslan Pharmaceuticals Ads | 0.0 | $2.2M | 2.0M | 1.12 | |
Bright Minds Biosciences | 0.0 | $2.1M | 661k | 3.23 | |
Adagene Ads (ADAG) | 0.0 | $2.1M | 263k | 8.07 | |
Aptinyx | 0.0 | $2.0M | 750k | 2.67 | |
Catalyst Biosciences Com New | 0.0 | $1.6M | 1.7M | 0.91 | |
Pyxis Oncology Common Stock (PYXS) | 0.0 | $1.6M | 144k | 10.97 | |
Landos Biopharma | 0.0 | $1.4M | 283k | 4.80 | |
Cabaletta Bio (CABA) | 0.0 | $1.1M | 303k | 3.79 | |
Longboard Pharmaceuticals In (LBPH) | 0.0 | $554k | 114k | 4.88 | |
Augmedix (AUGX) | 0.0 | $278k | 88k | 3.15 | |
Owlet *w Exp 09/14/202 (OWLTW) | 0.0 | $86k | 221k | 0.39 |